https://www.openbell.ai/ 2026-10-12T18:37:16.901Z hourly 1.0 https://www.openbell.ai/support 2026-10-12T18:37:16.901Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-12T18:37:16.901Z monthly 0.5 https://www.openbell.ai/terms 2026-10-12T18:37:16.901Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-12T18:37:16.901Z hourly 0.8 https://www.openbell.ai/news/BTCUSD:1791829703158 2026-10-12T18:28:23.158Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Bitcoin.jpg?width=250&height=187 Bitcoin Struggles in October: What's Causing the Weakness? Bitcoin (BTC) has experienced a pullback after reaching $87,000, dipping below $81,000 before a weekend rebound. The decline was driven by bearish sentiment among perpetual futures traders and a significant reversal in spot ETF flows, which shifted from $117.95 million in inflows to $701.57 million in outflows. Despite this, capital flow indicators showed growth, with monthly realized-cap increasing to 1.23% and a rise in short-term holder supply ratio to 14.52%. However, profitability metrics indicated a decrease in the supply in profit, falling to 71.41% from 74.47%. https://www.openbell.ai/news/BMBL:1791829517290 2026-10-12T18:25:17.290Z daily 0.9 https://cdn.brandfetch.io/BMBL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bumble Shares Halted On Circuit Breaker To The Upside, Stock Now Up 21.26% openbell Financial News https://www.openbell.ai/news/V:1791829489718 2026-10-12T18:24:49.718Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/VISA--Mastercard--And-American-Express-C.jpg?width=250&height=187 Visa Stock on Pace for Record Close: What's Going On? Visa Inc (NYSE: V) shares are experiencing an upward trend, currently trading at $391.26, marking a new all-time high. Baird analyst David Koning raised the price target for Visa to $430, anticipating a slight beat in fourth-quarter revenue and earnings. However, he projects a slowdown in fiscal 2027 sales growth to the high single digits or low double digits, down from approximately 14% in fiscal 2026. Visa's stock has risen 14.03% year-over-year and is currently considered overbought with a relative strength index (RSI) of 71.1. https://www.openbell.ai/news/EBAY:1791829389818 2026-10-12T18:23:09.818Z daily 0.9 https://cdn.brandfetch.io/EBAY/w/400/h/400?c=1idopYfmtR7ZKg8QMud eBay shares are trading higher after Morgan Stanley elevated eBay to a Top Pick, maintained its Overweight rating, and raised the price target from $127 to $132. openbell Financial News https://www.openbell.ai/news/COMP:1791829343130 2026-10-12T18:22:23.130Z daily 0.9 https://cdn.brandfetch.io/COMP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Compass shares are trading lower after Wells Fargo lowered its price target on the stock from $13 to $10. openbell Financial News https://www.openbell.ai/news/META:1791829103570 2026-10-12T18:18:23.570Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Meta Platforms shares are trading higher. The company announced Muse Wonder, its new family of frontier models with state-of-the-art performance for personal and professional agentic work. openbell Financial News https://www.openbell.ai/news/DKNG:1791829049243 2026-10-12T18:17:29.243Z daily 0.9 https://cdn.brandfetch.io/DKNG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Thursday October 8, 2026: "Seminole Tribe Sues Over DraftKings Predictions in Florida" - Bloomberg Law The Seminole Tribe has filed a lawsuit against DraftKings regarding predictions made in the Florida market. The legal action is part of an ongoing dispute over the company's operations in the state. The outcome of this lawsuit could have significant implications for DraftKings' business strategy and market presence in Florida. https://www.openbell.ai/news/MU:1791829029722 2026-10-12T18:17:09.722Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud China’s 4F² Threat to Micron—Houthis' Deadly Attack On Saudi Arabia Eclipses Trump’s Russian Diesel Deal China's ChangXin Memory Technologies has made significant advancements in 4F² memory chip technology, which could increase memory density by up to 50% while reducing manufacturing costs. This poses a potential competitive threat to Micron Technology Inc (NASDAQ: MU), as ChangXin plans to launch a product by the end of the year. The semiconductor industry is closely watching whether ChangXin can produce these chips at scale with acceptable yields and costs, which could impact memory supply and pricing. https://www.openbell.ai/news/BMBL:1791828932177 2026-10-12T18:15:32.177Z daily 0.9 https://cdn.brandfetch.io/BMBL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Dating App Stocks; Shares See Volume To The Upside After WSJ Reports 'Bumble In Advanced Talks To Go Private' openbell Financial News https://www.openbell.ai/news/CHRD:1791828854189 2026-10-12T18:14:14.189Z daily 0.9 https://cdn.brandfetch.io/CHRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Chord Energy, Raises Price Target to $195 Truist Securities analyst Gabe Daoud has reaffirmed a Buy rating on Chord Energy (NASDAQ: CHRD) and increased the price target from $180 to $195. This adjustment reflects a positive outlook for the company's performance. https://www.openbell.ai/news/BMBL:1791828844309 2026-10-12T18:14:04.309Z daily 0.9 https://cdn.brandfetch.io/BMBL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bumble shares are trading higher following reports suggesting that the company is in advanced talks to be taken private in a deal that values it at roughly $1 billion. openbell Financial News https://www.openbell.ai/news/BLCO:1791828784579 2026-10-12T18:13:04.579Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Trader-Investor-Broker-Using-Smartphone-.jpg?width=250&height=187 Why Is Bausch + Lomb Stock Falling Monday? Bausch + Lomb Corp. (NYSE: BLCO) experienced a nearly 10% drop in stock price on Monday, following the announcement of an unexpected leadership change. Thomas J. Appio has been appointed as interim CEO, replacing Brent Saunders, who left the company after a mutual agreement with the board. Despite this shake-up, Bausch + Lomb and its parent company, Bausch Health, are signaling stronger full-year 2026 earnings, with expectations to raise their adjusted EBITDA guidance, although specific revised earnings forecasts have not been disclosed. https://www.openbell.ai/news/OVV:1791828768575 2026-10-12T18:12:48.575Z daily 0.9 https://cdn.brandfetch.io/OVV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Ovintiv, Raises Price Target to $77 Truist Securities analyst Gabe Daoud has maintained a 'Buy' rating on Ovintiv (NYSE: OVV) and increased the price target from $73 to $77. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/PR:1791828730140 2026-10-12T18:12:10.140Z daily 0.9 https://cdn.brandfetch.io/PR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Permian Resources, Raises Price Target to $28 Truist Securities analyst Gabe Daoud has maintained a Buy rating on Permian Resources (NYSE: PR) and increased the price target from $24 to $28. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/BMBL:1791828660971 2026-10-12T18:11:00.971Z daily 0.9 https://cdn.brandfetch.io/BMBL/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Dating App Bumble In Advanced Talks To Go Private At $1 Billion Valuation; Founder Whitney Wolfe Herd Expected To Stay Involved With Company As Part Of Deal' - WSJ Exclusive Bumble, the dating app, is in advanced discussions to go private with a valuation of $1 billion. Founder Whitney Wolfe Herd is expected to remain involved with the company as part of the deal. The move signifies a strategic shift for Bumble amid its current market positioning. https://www.openbell.ai/news/PKG:1791828232934 2026-10-12T18:03:52.934Z daily 0.9 https://cdn.brandfetch.io/PKG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Packaging Corp of America, Raises Price Target to $280 Truist Securities analyst Michael Roxland has maintained a Buy rating on Packaging Corp of America (NYSE: PKG) and raised the price target from $270 to $280. https://www.openbell.ai/news/INV:1791828192604 2026-10-12T18:03:12.604Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Volatility.jpg?width=250&height=187 What's Going On With Innventure Stock Monday? Innventure Inc. (NASDAQ: INV) announced that its backed company, Accelsius, has upgraded its Springdale facility in Austin, Texas, to multi-megawatt power capacity for testing advanced liquid cooling systems for AI data centers. Following this announcement, Innventure's stock surged 7.41% to $0.2894, with a market capitalization of approximately $23.4 million. Accelsius plans to expand the facility by adding 18,000 square feet by January 2027 and is developing a new 375-kilowatt NeuCool cooling unit to enhance its product lineup. https://www.openbell.ai/news/BTCUSD:1791828039566 2026-10-12T18:00:39.566Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Coin-Bitcoin--Eth-And-Xrp-On-Background-.jpg?width=250&height=187 Bitcoin Drops Below $83,000, Ethereum Down 1%, XRP, Dogecoin Plunge 3% Bitcoin has dropped below $83,000, currently priced at $82,418.78, influenced by elevated Treasury yields and a stronger dollar, alongside uncertainty surrounding the U.S. midterm elections. Ethereum is down 1% at $2,506.36, while XRP and Dogecoin have plunged 3% to $1.36 and $0.08468, respectively. In the past 24 hours, 88,688 traders were liquidated for a total of $302.44 million, with Bitcoin ETFs seeing net inflows of $21.13 million and Ethereum ETFs experiencing outflows of $56.1 million. https://www.openbell.ai/news/OEC:1791827789083 2026-10-12T17:56:29.083Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Cybersecurity.png?width=250&height=187 What 10-K Filings Reveal About Deepfake Risks And Earnings Impact Orion S.A. (NYSE: OEC) reported a pre-tax charge of $59.3 million in 2024 due to an employee being deceived into wiring funds to criminals, which represents approximately 58% of the company's operating income for that year. The company recorded $55.7 million in unrecovered transfers and $3.6 million in investigation fees, leading to a decline in income from operations to $102.7 million in 2024, down from $205.3 million in 2023. Additionally, Orion's stock traded at $5.93 on September 21, 2024, reflecting a market value of about $335 million, with the fraud charge alone equating to nearly 18% of that value. https://www.openbell.ai/news/LCID:1791827537903 2026-10-12T17:52:17.903Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Lucid-Group.jpg?width=250&height=187 Lucid Stock Under Pressure as Analyst Sees Revenue, Margin Risks Lucid Group, Inc. (NASDAQ: LCID) is facing pressure as RBC Capital analyst Tom Narayan lowered the price target due to a weak third-quarter delivery report, revealing a 24% year-over-year production decline to 2,954 vehicles. The analyst projects a revenue of $351 million for the quarter, below consensus, and anticipates weaker gross margins. Additionally, Lucid plans to open its first three retail and service locations in France in Q1 2027, aiming to expand to over 16 locations by the end of that year. As of the latest report, Lucid's stock was down 8.71% at $3.46. https://www.openbell.ai/news/REXR:1791827468913 2026-10-12T17:51:08.913Z daily 0.9 https://cdn.brandfetch.io/REXR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Rexford Industrial Realty, Raises Price Target to $39 Truist Securities analyst Anthony Hau has reiterated a Buy rating on Rexford Industrial Realty (NYSE: REXR) and increased the price target from $38 to $39. https://www.openbell.ai/news/HUM:1791827104869 2026-10-12T17:45:04.869Z daily 0.9 https://cdn.brandfetch.io/HUM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oppenheimer Maintains Outperform on Humana, Raises Price Target to $525 Oppenheimer analyst Michael Wiederhorn has maintained an 'Outperform' rating on Humana (NYSE: HUM) and increased the price target from $475 to $525. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/SPY:1791827083829 2026-10-12T17:44:43.829Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fed's Hammack Says There Is More Restraint That Is Needed; If Monetary Policy Does Nothing Market Conditions Would Change; Comments From Low Income Workers Was First About Trading Down, Now They Are Beginning To Juggle What Bills To Pay openbell Financial News https://www.openbell.ai/news/AI:1791826970528 2026-10-12T17:42:50.528Z daily 0.9 https://cdn.brandfetch.io/AI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Northland Capital Markets Upgrades C3.ai to Outperform, Raises Price Target to $16 Northland Capital Markets has upgraded C3.ai (NYSE: AI) from Market Perform to Outperform. The price target for the stock has been raised from $10 to $16, reflecting a positive outlook for the company's performance. https://www.openbell.ai/news/SDGR:1791826858411 2026-10-12T17:40:58.411Z daily 0.9 https://cdn.brandfetch.io/SDGR/w/400/h/400?c=1idopYfmtR7ZKg8QMud BMO Capital Maintains Outperform on Schrodinger, Raises Price Target to $30 BMO Capital analyst Gary Nachman has maintained an 'Outperform' rating on Schrodinger (NASDAQ: SDGR) and raised the price target from $24 to $30. https://www.openbell.ai/news/AMGN:1791826650335 2026-10-12T17:37:30.335Z daily 0.9 https://cdn.brandfetch.io/AMGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud BMO Capital Maintains Market Perform on Amgen, Lowers Price Target to $415 BMO Capital analyst Evan David Seigerman has maintained a Market Perform rating on Amgen (NASDAQ: AMGN) while lowering the price target from $450 to $415. This adjustment reflects a revised outlook on the company's performance. https://www.openbell.ai/news/DAL:1791826603921 2026-10-12T17:36:43.921Z daily 0.9 https://cdn.brandfetch.io/DAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud BMO Capital Maintains Outperform on Delta Air Lines, Raises Price Target to $105 BMO Capital analyst Michael Goldie has maintained an Outperform rating on Delta Air Lines (NYSE: DAL) and raised the price target from $100 to $105. This adjustment reflects a positive outlook for the airline's performance in the market. https://www.openbell.ai/news/EBAY:1791826541571 2026-10-12T17:35:41.571Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Close-Up-Of-Ebay-Sign-At-Its-Headquarter.jpg?width=250&height=187 EBay Stock Jumps: What's Going On? EBay Inc (NASDAQ: EBAY) shares rose 3.51% to $116.13 following Morgan Stanley's designation of the stock as a Top Pick, increasing the price target from $127 to $132. Analyst Nathan Feather highlighted a 14% rise in gross merchandise volume (GMV) on an FX-neutral basis, attributing growth to the live commerce market, which is projected to triple GMV from $8 billion to $24 billion by 2030. Despite this positive outlook, Wells Fargo maintained an Underweight rating with a reduced price target of $91. https://www.openbell.ai/news/REGN:1791826498188 2026-10-12T17:34:58.188Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Female-Doctor-And-Patient-Reviewing-And-.jpg?width=250&height=187 Regeneron Says Newly Approved Drug Shows Sustained Efficacy In Halting Rogue Bone Growth Regeneron Pharmaceuticals Inc. announced positive 84-week results from the Phase 3 OPTIMA trial for its drug Pasatru (garetosmab-grts), which effectively halts abnormal bone growth in adults with fibrodysplasia ossificans progressiva (FOP). The trial demonstrated no new heterotopic ossification lesions in the Pasatru group from week 56 to 84, compared to nine in the placebo group. Following these results, Regeneron shares rose by 2.66% to $766.38, and the company plans to initiate a Phase 3 trial for adolescents and children with FOP later this year. https://www.openbell.ai/news/EXC:1791826178276 2026-10-12T17:29:38.276Z daily 0.9 https://cdn.brandfetch.io/EXC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Richardson Electronics And Exelon Unit ComEd Announce Expansion Of Locally Produced Battery Energy Storage Systems And Plans To Install An Onsite Battery Energy Storage System Demonstration Project Richardson Electronics is expanding its locally produced battery energy storage systems in collaboration with Exelon's ComEd, aiming to enhance grid reliability and support renewable energy integration. The company is currently constructing the largest commercial battery storage system in Illinois and plans to install a 5-MWh research and development demonstration project. This initiative is part of the REV Illinois program, which supports energy technology manufacturing and economic growth in the region. https://www.openbell.ai/news/USO:1791826141274 2026-10-12T17:29:01.274Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Supertankers Turn From Gulf Oil Transfer Hub Amid Iran’s Attacks' - Bloomberg Supertankers are shifting away from the Gulf oil transfer hub due to increased attacks from Iran, impacting oil transportation routes. This change is likely to affect supply chains and could lead to higher shipping costs. The situation has raised concerns in the oil market, potentially influencing stock prices and trading strategies for companies involved in oil transportation. https://www.openbell.ai/news/USO:1791826034572 2026-10-12T17:27:14.572Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oil is trading higher after Iran reported that a crude oil supertanker was hit and caught fire in the Strait of Hormuz. The upward move is also supported by reports that Iran-backed Houthi militants in Yemen attacked King Khalid International Airport in Riyadh, Saudi Arabia, on Saturday, adding to concerns over regional instability. openbell Financial News https://www.openbell.ai/news/KR:1791825731728 2026-10-12T17:22:11.728Z daily 0.9 https://cdn.brandfetch.io/KR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Albertsons Demands Kroger Pay Substantial Damages Over Failure Of Previously Announced Proposed Merger Albertsons is seeking substantial damages from Kroger due to the failure of their previously announced proposed merger. The legal action highlights the complexities and financial implications surrounding the merger negotiations between the two grocery giants. The outcome of this dispute could have significant impacts on both companies' financial standings and market strategies. https://www.openbell.ai/news/TROX:1791825661731 2026-10-12T17:21:01.731Z daily 0.9 https://cdn.brandfetch.io/TROX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Maintains Sell on Tronox Holdings, Lowers Price Target to $4 Goldman Sachs analyst Duffy Fischer has maintained a 'Sell' rating on Tronox Holdings (NYSE: TROX) and reduced the price target from $6.5 to $4. This adjustment reflects the firm's outlook on the company's performance. https://www.openbell.ai/news/LPX:1791825607155 2026-10-12T17:20:07.155Z daily 0.9 https://cdn.brandfetch.io/LPX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Maintains Sell on Louisiana-Pacific, Lowers Price Target to $64 Goldman Sachs analyst Susan Maklari has maintained a 'Sell' rating on Louisiana-Pacific (NYSE: LPX) and has reduced the price target from $74 to $64. This adjustment reflects the firm's outlook on the company's performance in the market. https://www.openbell.ai/news/SKYA:1791825564198 2026-10-12T17:19:24.198Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Investors-Show-Virtual-Screen-Stock-Mark.jpg?width=250&height=187 Why Is SkyAI Stock Surging Monday? SkyAI, Inc. (NASDAQ: SKYA) stock surged 24.68% to $2.26 in premarket trading after announcing a cash tender offer worth up to $201 million to repurchase up to 95% of its outstanding common shares at $3 per share, representing a 65% premium to its Oct. 9 closing price. The tender offer, expected to launch around Oct. 15 and remain open for 10 business days, will be funded using existing cash and proceeds from recent sales of Solana tokens. Additionally, SkyAI's board rejected an unsolicited acquisition proposal from Forward Industries, citing undervaluation of the company. https://www.openbell.ai/news/TRAX:1791825559354 2026-10-12T17:19:19.354Z daily 0.9 https://cdn.brandfetch.io/TRAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is First Tracks Biotherapeutics Stock Soaring Monday? First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX) saw its stock rise over 13% following the release of positive topline results from Cohort 1 of its Phase 1b clinical trial for ANB033 in celiac disease. The trial demonstrated that ANB033 effectively protected against gluten-induced intestinal damage and significantly reduced gastrointestinal symptoms compared to placebo. The study involved 32 patients, with ANB033 meeting all key histologic efficacy endpoints and showing favorable safety with no serious adverse events. The company plans to prepare for a late-stage celiac trial in 2027 and has additional trials planned for other indications. https://www.openbell.ai/news/TRAX:1791825536438 2026-10-12T17:18:56.438Z daily 0.9 https://cdn.brandfetch.io/TRAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is First Tracks Biotherapeutics Stock Soaring Monday? First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX) saw its stock rise over 13% following the release of positive topline results from Cohort 1 of its Phase 1b clinical trial for ANB033, an investigational treatment for celiac disease. The trial demonstrated that ANB033 protected against gluten-induced intestinal damage and significantly reduced gastrointestinal symptoms compared to placebo. The company plans to align with regulatory agencies for a late-stage celiac trial in 2027 and expects further trial results in the coming years. https://www.openbell.ai/news/TRAX:1791825519737 2026-10-12T17:18:39.737Z daily 0.9 https://cdn.brandfetch.io/TRAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is First Tracks Biotherapeutics Stock Soaring Monday? First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX) saw its stock rise by over 13% following the release of positive topline results from Cohort 1 of its Phase 1b clinical trial for ANB033, an investigational treatment for celiac disease. The trial demonstrated that ANB033 significantly protected against gluten-induced intestinal damage and alleviated gastrointestinal symptoms compared to a placebo. The company plans to prepare for a late-stage celiac trial in 2027 and has additional trials in the pipeline for other conditions. https://www.openbell.ai/news/SKYA:1791825517896 2026-10-12T17:18:37.896Z daily 0.9 https://cdn.brandfetch.io/SKYA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is SkyAI Stock Surging Monday? SkyAI, Inc. (NASDAQ: SKYA) stock surged 24.68% to $2.26 in premarket trading after announcing a cash tender offer worth up to $201 million to repurchase up to 95% of its outstanding common shares and several classes of warrants at $3 per share. The offer represents a 65% premium to the company's closing price on October 9 and is expected to launch around October 15, remaining open for 10 business days. Additionally, SkyAI's board rejected an unsolicited acquisition proposal from Forward Industries, citing undervaluation concerns. https://www.openbell.ai/news/TRAX:1791825490574 2026-10-12T17:18:10.574Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Medical--Research-And-Scientist-In-Labor.jpg?width=250&height=187 Why Is First Tracks Biotherapeutics Stock Soaring Monday? First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX) saw its stock price jump over 13% following the release of positive topline results from Cohort 1 of its Phase 1b clinical trial for ANB033, an investigational treatment for celiac disease. The trial demonstrated significant efficacy in protecting against gluten-induced intestinal damage and alleviating gastrointestinal symptoms in study participants. The company plans to align with regulatory agencies for a late-stage celiac trial in 2027 and is also preparing for additional trials in eosinophilic esophagitis and vitiligo. https://www.openbell.ai/news/SKYA:1791825486754 2026-10-12T17:18:06.754Z daily 0.9 https://cdn.brandfetch.io/SKYA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is SkyAI Stock Surging Monday? SkyAI, Inc. (NASDAQ: SKYA) stock surged 24.68% to $2.26 in premarket trading following the announcement of a cash tender offer worth up to $201 million, aimed at repurchasing up to 95% of its outstanding common shares and several classes of warrants at $3 each. The offer represents a 65% premium over the company's closing price on October 9 and is expected to launch around October 15, lasting for 10 business days. Additionally, SkyAI's board rejected a takeover proposal from Forward Industries, citing undervaluation concerns. https://www.openbell.ai/news/ZETA:1791825440507 2026-10-12T17:17:20.507Z daily 0.9 https://cdn.brandfetch.io/ZETA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Reiterates Buy on Zeta Global Holdings, Raises Price Target to $55 Roth Capital analyst Richard Baldry has reiterated a Buy rating on Zeta Global Holdings (NYSE: ZETA) and increased the price target from $44 to $55. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/INV:1791825386319 2026-10-12T17:16:26.319Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Volatility.jpg?width=250&height=187 What's Going On With Innventure Stock Monday? Innventure Inc. (NASDAQ: INV) saw its shares rise by 7.41% to $0.2894 following the announcement that its backed company, Accelsius, upgraded its Springdale facility in Austin, Texas, to multi-megawatt power capacity for testing advanced liquid cooling systems for AI data centers. The expansion includes adding 18,000 square feet by January 2027 and will enable testing of high-density racks under future power requirements, which could exceed 1 megawatt. Accelsius is also developing a new 375-kilowatt NeuCool cooling unit and has launched a program for hyperscale data center operators to test its technology. https://www.openbell.ai/news/MANH:1791825353873 2026-10-12T17:15:53.873Z daily 0.9 https://cdn.brandfetch.io/MANH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Manhattan Associates shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight rating and raised its price target from $180 to $250. openbell Financial News https://www.openbell.ai/news/META:1791825275287 2026-10-12T17:14:35.287Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Mark Zuckerberg says Meta has reached AI ‘frontier’ and rejects calls for slowdown' - FT Interview In a recent interview, Mark Zuckerberg stated that Meta has reached a significant milestone in artificial intelligence development, referring to it as the 'frontier.' He dismissed suggestions for the company to slow down its AI initiatives, emphasizing the importance of continued innovation in this area. The remarks come amid ongoing discussions about the ethical implications and regulatory scrutiny of AI technologies. https://www.openbell.ai/news/SMP:1791825220478 2026-10-12T17:13:40.478Z daily 0.9 https://cdn.brandfetch.io/SMP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Reiterates Buy on Standard Motor Products, Maintains $54 Price Target Roth Capital analyst Scott Stember has reiterated a Buy rating on Standard Motor Products (NYSE: SMP) and has maintained a price target of $54 for the stock. This endorsement reflects confidence in the company's performance and potential for growth. https://www.openbell.ai/news/COAG:1791825163198 2026-10-12T17:12:43.198Z daily 0.9 https://cdn.brandfetch.io/COAG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rodman & Renshaw Initiates Coverage On Hemab Therapeutics Hldgs with Buy Rating, Announces Price Target of $56 Rodman & Renshaw analyst Michael G. King Jr. has initiated coverage on Hemab Therapeutics Holdings (NASDAQ: COAG) with a Buy rating. The firm has set a price target of $56 for the stock. https://www.openbell.ai/news/ORCL:1791824997663 2026-10-12T17:09:57.663Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Oracle-Corp.jpg?width=250&height=187 Why Is Oracle Stock Falling on Monday? Oracle Corp. (NYSE: ORCL) shares fell 3.10% to $137.02 on Monday, influenced by profit-taking and negative sentiment surrounding AI stocks after OpenAI reported its annualized revenue at approximately $50 billion, lower than the previously expected $70 billion. The broader market also faced pressure, with the Nasdaq down 0.55% and technology stocks declining 1.12%. Concerns about OpenAI's revenue performance have raised doubts regarding Oracle's AI infrastructure investments and future growth prospects. https://www.openbell.ai/news/MIRM:1791824955909 2026-10-12T17:09:15.909Z daily 0.9 https://cdn.brandfetch.io/MIRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $200 HC Wainwright & Co. analyst Swayampakula Ramakanth has maintained a Buy rating on Mirum Pharmaceuticals (NASDAQ: MIRM) and raised the price target from $195 to $200.